Bertrand William C JR
SEC-identified person · CIK 1291937 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Ardelyx, INC. ARDX | Director | filed 2015–2026 |
| Adaptimmune Therapeutics PLC ADAP] | Chief Operating Officer | filed 2017–2025 |
| Infinity Pharmaceuticals, INC. INFI | General Counsel | filed 2015–2015 |
| Salix Pharmaceuticals LTD SLXP | See Remarks | filed 2013–2015 |
| Santarus INC SNTS | Director · Secretary | filed 2014–2014 |
| Medimmune INC /DE MEDI | Senior VP, General Counsel | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.